Showing results (1-10 of 80) with videos related to
Sort By:
Pageof 8
Vaccine|January 1, 1992
Clinical assessment of the safety and efficacy of an inactivated hepatitis A vaccine: rationale and summary of findingsF E André, E D'Hondt, A Delem, et al.Vaccine|January 1, 1993
Characterization of the immune response of volunteers vaccinated with a killed vaccine against hepatitis AA Delem, A Safary, F De Namur, et al.Vaccine|April 1, 1997
Inactivated hepatitis A vaccine: long-term antibody persistenceG Wiedermann, M Kundi, F Ambrosch, et al.Lancet (London, England)|May 5, 1984
Protection of infants against rotavirus diarrhoea by RIT 4237 attenuated bovine rotavirus strain vaccineT Vesikari, E Isolauri, E D'Hondt, et al.Vaccine|January 1, 1992
Persistence of vaccine-induced antibody to hepatitis A virusG Wiedermann, F Ambrosch, F E André, et al.Lancet (London, England)|October 8, 1983
Immunogenicity and safety of live oral attenuated bovine rotavirus vaccine strain RIT 4237 in adults and young childrenT Vesikari, E Isolauri, A Delem, et al.Vaccine|January 1, 1992
Simultaneous vaccination against hepatitis A and B: results of a controlled studyF Ambrosch, F E André, A Delem, et al.The Journal of Pediatrics|August 1, 1985
Clinical efficacy of the RIT 4237 live attenuated bovine rotavirus vaccine in infants vaccinated before a rotavirus epidemicT Vesikari, E Isolauri, A Delem, et al.The Journal of Hygiene|October 1, 1977
Protective efficacy of RIT 4025, a live attenuated influenza vaccine strain, and evaluation of heterotypic immunity to influenza A viruses in ferretsA DelemDevelopments in Biological Standardization|June 1, 1977
Serum SRH antibody level as a measure of the immunity against natural and artificial A/Victoria/3/75 infectionsA DelemPageof 8